(PinkSheets:RNWF),(Pinksheets:RNWF), Fusion platform positioned for military, commercial, residential, and remote deployments via power purchase agreements. SOUTHLAKE, Texas, Jan. 08, 2026 (GLOBE NEWSWIRE) — Renewal Fuels, Inc. (OTC: RNWF) (“RNWF” or the “Company”), together with Kepler Fusion Technologies Inc. (“Kepler”), announced the release of a new interview with Brent Nelson, Chief Executive Officer of Kepler Fusion […]

(NASDAQ:DGNX),(Boerse Frankfurt – Freiverkehr:I0Q.F),(Tradegate:I0Q.F), LONDON, Jan. 08, 2026 (GLOBE NEWSWIRE) — Diginex Limited (NASDAQ: DGNX), (“Diginex” or the “Company”), a leading provider of Sustainability RegTech solutions, today announced the successful closing of its acquisition of The Remedy Project Limited (“The Remedy Project”), a Hong Kong based advisory and research organization specializing in labor and human

FORT WORTH, Texas, Jan. 08, 2026 (GLOBE NEWSWIRE) — Vickery Energy Partners, LLC (“Vickery”), a portfolio company of Quantum Capital Group, announced today that it has closed on the acquisition of Tribune Resources, LLC from Tribune Resources, Inc (“Tribune”). The transaction includes assets located primarily in Wetzel, Tyler, Harrison and Doddridge counties, West Virginia, spanning

Boothwyn, PA., Jan. 08, 2026 (GLOBE NEWSWIRE) — Pentec Health, Inc. (Pentec) today announced the acquisition of Hartley Medical Center Pharmacy, LLC (Hartley Medical), a nationally recognized compounding pharmacy focused on the sterile compounding of intrathecal (IT) medications used to treat chronic pain and spasticity. Hartley Medical will continue operating from its Long Beach, California

CHICAGO, Jan. 08, 2026 (GLOBE NEWSWIRE) — R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced the launch of Phare Audit, the most comprehensive AI-native solution for both coding and clinical documentation integrity. It is designed to transform mid-revenue cycle performance by improving accuracy and quality before a bill is generated

(NASDAQ:AMPG),(NASDAQ:AMPGW), HAUPPAUGE, N.Y., Jan. 08, 2026 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), is pleased to announce the appointment of Prof. Tommaso Melodia to its Board of Advisors, effective immediately. Professor Tommaso Melodia brings over two decades of leadership in wireless communications, next-generation network architectures, and artificial intelligence applied to wireless systems. He

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — G Squared, a leading global venture capital firm specializing in private secondary markets, and Nasdaq Private Market (NPM), a leading provider of liquidity programs and investment opportunities for private companies, employee shareholders, and investors, today announced a strategic alliance to facilitate and fund company-driven secondary liquidity events.

(NASDAQ:RVPH), Findings reinforce brilaroxazine's treatment effect on negative symptoms and other symptom domains in schizophrenia and support clinician-assessed efficacy outcomes in a Phase 3 trial of brilaroxazine Findings also support use of speech latency as an enrichment tool that can reduce sample-size and enhance outcomes in clinical trials for schizophrenia CUPERTINO, Calif., Jan. 08, 2026

MIAMI, Jan. 08, 2026 (GLOBE NEWSWIRE) — RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today provided a corporate update and announced its strategic priorities for 2026. “We had a remarkable 2025, where we made significant progress across our pipeline of advanced cell therapeutics. In

(NASDAQ:GRI), New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung function LA JOLLA, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of immune cell modulators for the treatment of inflammatory,